The global bone regeneration market is poised for remarkable growth, with projections estimating its value to surge from USD 5,380.75 million in 2023 to USD 7,827.8 million by 2033. This growth is ...

After starting his career holding numerous roles with increasing levels of responsibility at Medtronic Spine and Biologics, he was a senior executive at NuVasive from 2001 until 2015. Mr ...

Reflecting on the robust synergies from the NuVasive merger, we anticipate that the latest acquisition should positively impact the market sentiment toward GMED stock. Globus Medical has a market ...

The Spinal Interbody Fusion Market is a critical segment of the orthopedic and neurosurgical medical device industry, focusing on the treatment of spinal disorders through surgical intervention.

The global Orthopedic Implants Market is valued at USD 47.38 Billion in 2024 and is projected to reach a value of USD 85.8 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 5.55% between 2025 ...

1) Cases with previous lumbar surgery. 2) Cases with previous spinal infection. 3) Other cases of lumbar interbody fusion (PLIF, TLIF). 4) Patients with incomplete records for culture results. Data ...

Therefore, the objective of this study is to comprehensively investigate the prevalence of kinesiophobia in patients following lumbar interbody fusion (LIF) by considering demographic characteristics, ...

NuVasive, Inc., a company focusing on minimally disruptive products and procedures, is announcing major executive leadership changes. Quentin Blackford has been promoted to the Executive Leadership ...

Patient accessibility to healthcare is a persistent challenge, and spine surgeons are using multiple strategies to manage it. Ask Spine Surgeons is a weekly series of questions posed to spine surgeons ...

Orthopaedics and RQM+, has completed the first proof-of-concept study of its electric transforaminal lumbar interbody fusion procedure. The e-TLIF integrates spinal fusion with nerve stimulation, ...